Department of Dermatology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, New York.
Department of Pathology & Cell Biology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, New York.
Cancer Res. 2021 Oct 1;81(19):5021-5032. doi: 10.1158/0008-5472.CAN-20-3251. Epub 2021 Jun 28.
The CD200-CD200R immunoregulatory signaling axis plays an etiologic role in the survival and spread of numerous cancers, primarily through suppression of antitumor immune surveillance. Our previous work outlined a prometastatic role for the CD200-CD200R axis in cutaneous squamous cell carcinoma (cSCC) that is independent of direct T-cell suppression but modulates the function of infiltrating myeloid cells. To identify effectors of the CD200-CD200R axis important for cSCC metastasis, we conducted RNA sequencing profiling of infiltrating CD11BCd200R cells isolated from CD200 versus CD200-null cSCCs and identified the cysteine protease cathepsin K (Ctsk) to be highly upregulated in CD200 cSCCs. CD11BCd200R cells expressed phenotypic markers associated with myeloid-derived suppressor cell-like cells and tumor-associated macrophages and were the primary source of Ctsk expression in cSCC. A Cd200R myeloid cell-cSCC coculture system showed that induction of Ctsk was dependent on engagement of the CD200-CD200R axis, indicating that Ctsk is a target gene of this pathway in the cSCC tumor microenvironment. Inhibition of Ctsk, but not matrix metalloproteinases, significantly blocked cSCC cell migration . Finally, targeted CD200 disruption in tumor cells and Ctsk pharmacologic inhibition significantly reduced cSCC metastasis . Collectively, these findings support the conclusion that CD200 stimulates cSCC invasion and metastasis via induction of Ctsk in CD200R infiltrating myeloid cells. SIGNIFICANCE: These findings highlight the relationship between CD200-CD200R and cathepsin K in cutaneous squamous cell carcinoma metastasis and suggest that either of these components may serve as a viable therapeutic target in this disease.
CD200-CD200R 免疫调节信号轴在许多癌症的存活和扩散中起病因作用,主要通过抑制抗肿瘤免疫监视。我们之前的工作概述了 CD200-CD200R 轴在皮肤鳞状细胞癌 (cSCC) 中的促转移作用,该作用独立于直接 T 细胞抑制,但调节浸润髓样细胞的功能。为了确定 CD200-CD200R 轴中对 cSCC 转移重要的效应物,我们对分离自 CD200 与 CD200 缺失的 cSCC 的浸润性 CD11B+CD200R 细胞进行了 RNA 测序分析,鉴定出半胱氨酸蛋白酶组织蛋白酶 K (Ctsk) 在 CD200 cSCC 中高度上调。CD11B+CD200R 细胞表达与髓源抑制细胞样细胞和肿瘤相关巨噬细胞相关的表型标志物,是 cSCC 中 Ctsk 表达的主要来源。在 CD200R 髓样细胞-cSCC 共培养系统中,Ctsk 的诱导依赖于 CD200-CD200R 轴的结合,表明 Ctsk 是该途径在 cSCC 肿瘤微环境中的靶基因。Ctsk 的抑制,而不是基质金属蛋白酶的抑制,显著阻断了 cSCC 细胞的迁移。最后,肿瘤细胞中靶向 CD200 的破坏和 Ctsk 的药物抑制显著减少了 cSCC 的转移。综上所述,这些发现支持 CD200 通过诱导浸润性 CD200R 髓样细胞中的 Ctsk 刺激 cSCC 侵袭和转移的结论。意义:这些发现强调了 CD200-CD200R 与皮肤鳞状细胞癌转移中的组织蛋白酶 K 之间的关系,并表明这些成分中的任何一种都可能成为该疾病的可行治疗靶点。